tert-Butyl (1-ethynylcyclopropyl)carbamate, 98%, 5g

1,1-Dimethylethyl N-(1α,3β,5α)-6-oxabicyclo[3.1.0]hex-3-ylcarbamate, 1g

(diazyn-1-ium-1-yl)(6-hydroxyhexyl)azanide, 95%, 10g

1,3-Dibromo-5-fluoro-2-(phenylmethoxy)benzene, 98%, 5g

2-Bromo-5-nitrothiazole, 95.0%, 10g

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)prop-2-en-1-ol, 95%, 250mg

(S,S)-(+)-2,3-Bis(tert-butylmethylphosphino)quinoxaline>98.0%(HPLC)100mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-cyanophenyl)propanoic acid, 95%, 5g

4-(4-Bromobutoxy)benzaldehyde, 98%, 5g

(R)-1,1,1-Trifluoro-3-methyl-2-butylamine, 97.0%, 250mg

3'-Fluoropropiophenone, 97.00%, 1g

trans-1,4-Cyclohexanedicarboxylic Acid>97.0%(GC)(T)500g

2-Methylenepropane-1,3-diol, 99.0%, 5g